Industry Research Reports

US: +1 800 986 6819

UK: +44 203 514 2363

India: +91 22 4098 7600

RELATED VIDEO:

Oil and Gas Business Confidence Report Q1 2014

Oil and gas Business Confidence Report Q1 2014 is a new report by Kable that analyzes oil and gas industry executives' views on the global economy, expectations on customer confidence, supplier prices, key business concerns, and how executives' future investments are set to change in Q1 2014. This report also gives you access to regional analysis of industry outlook, industry and company growth prospects, future opportunities, staff hiring, sales performance, and procurement budget allocation, and expenditure outlook. Apart from providing access to the opinions and strategies of global oil and gas industry executives, it also examines their actions surrounding business priorities, threats and opportunities, and future investment areas over the next six months. Moreover, this report provides a comparative analysis of survey results with Q4 2013 wherever applicable.

Introduction and Landscape

* Why was the report written?

- This report is the result of an extensive survey drawn from Kable's exclusive panel of leading global oil and gas industry executives. The report analyzes current economic conditions prevailing across the globe and their impact on the oil and gas industry, and forecasts company and industry growth prospects over the next six months. Furthermore, it provides information about the impact of customer confidence, supplier prices, staff headcount, and procurement budget and expenditure likely to affect the investment decisions of the industry over the next six months. Additionally, this report tracks the change in executives' perceptions during the last three months, by providing a comparative analysis of survey results with the previous quarter.

* What is the current market landscape and what is changing?

- Overall, 69% and 65% of global oil and gas industry executives are optimistic about the future growth prospects of both their company and the industry, respectively, over the next six months. Optimism towards both company and industry growth prospects has reduced in Q1 2014, compared to Q4 2013 results.

* What are the key drivers behind recent market changes?

- Optimism towards industry and company growth has reduced due to factors such as continuation of the Euro-zone crisis, rising exploration costs, new competition, and lack of political stability or social unrest in areas of operation.

* What makes this report unique and essential to read?

- Oil and gas Business Confidence Report Q1 2014 is a new report by Kable that analyzes the industries sentiments globally on the latest economic and customer issues, and their impact upon investment decisions and growth prospects within the oil and gas industry. This report also examines the executive opinion about the current and future state of the economy and its retrospective effect on the industry. Furthermore, it analyzes the likely effect of supplier price changes, sales performance, procurement expenditure outlook, and staff headcount within the industry over the next six months. In addition, it provides an overview of the key priorities, threats, and opportunities for the global oil and gas industry over the next six months. Furthermore, it also tracks the change in industry executives' thought process, by providing a comparative analysis of survey results with Q4 2013, wherever applicable.

Key Features and Benefits

* Project industry trends and industry growth expectations in the next six months, and understand business confidence to make informed business decisions.

* The report drives revenues by understanding future product investment areas and key growth regions.

* Readers will be provided with a clear uncovering of key challenges and opportunities, and identify the key priorities likely to affect growth prospects of the industry.

* The report clearly forecasts the change in supplier prices for various products and procurement budgets of oil and gas companies which are likely to influence the industry's growth prospects over the next six months.

* Identifies the major changes in customer confidence levels in the oil and gas industry over the next six months.

Key Market Issues

* According to oil and gas industry respondents, the present economic conditions in Africa and East Europe are deemed to be unfavorable. In the Q4 2013 survey, West Europe was highlighted as the most unfavorable.

* New government proposals/legislation and the state of the global economy are the key concerns among global oil and gas industry executives.

* Survey respondents forecast that supplier prices for power and energy will increase at an average of 4%, with those from North America expecting the biggest rise.

* In total, 40% of global oil and gas industry executives anticipate either 'no change' or a 'negative change' in customer confidence over the industry, in the next six months.

* Industry executives exhibit lower levels of optimism towards both company and industry growth prospects for the next six months compared to last quarter.

Key Highlights

Of respondents, 64% anticipate a positive change in the global economic outlook over the next six months. In comparison to the previous quarter, the percentage of respondents who expect a positive change has increased slightly.

Oil and gas industry executives plan to increase investments in the areas of IT and research and analysis in the next six months.

Oil and gas executives from North America anticipate the highest increase in both staff head count and sales, at an average of 4% and 6.2% respectively, over the next six months. Executives from the Rest of the World expect the smallest increase in staff head count and sales at an average of 2.6% and 3.5% respectively, in the next six months.

Companies plan to spend more on services, and equipment and machinery in 2014, with the highest spend of the services budget going towards construction and engineering services, and consulting and training services.

Executives operating across the globe consider 'increasing sales', 'improving operational efficiency', 'protecting and growing market share', and 'customer retention' as key priorities over the next six months.

To order this report:

US: +1 800 986 6819

UK: +44 203 514 2363

India: +91 22 4098 7600

Medical Devices Market in India 2014

RELATED VIDEO:

Wednesday 26 March 2014

Medical Devices Market in India 2014

Netscribes latest market research report titled Medical Devices Market in India 2014 captures the technologically driven aspect currently prevailing within the Indian healthcare sector. The booming Indian economy is also witnessing a tremendous surge in the domestic healthcare scenario which, in turn, is leading to perpetual demand for high quality medical products. The demand for high-end, quality devices is especially driven by the private healthcare sector in its efforts to provide sophisticated treatment to patients. However, India lags behind in manufacture of technologically advanced high-end medical equipment, and instead has to rely upon imports from multinationals with extensive service networks. On the other hand, the market for less cost intensive medical supplies and disposable equipment is dominated by domestic manufacturers.

Due to the industry’s dependence on imports, multinationals are showing interest in relocation of manufacturing facilities to India as well as in forging alliances with healthcare sector stakeholders in order to capture greater market share. This brings into focus a key role played by the government that involves taxation and import regulations. The government also takes up several initiatives for the benefit of the market.

Coverage

* Overview of the medical devices market in India and forecasted market size data over 2012 to 2018

* Market Segmentation of medical devices by types

* Overview of the medical devices market in India by types and forecasted market size data over 2012 to 2018

* Snapshot of market segmentation of medical equipment

* New and Refurbished Medical Equipment

* Regional Demand for Medical Equipment

* Export-import overview of medical devices, value of export-import over 2009-10 to 2012-13 and country-wise value of export-import for 2011-12 and 2012-13

* Qualitative analysis of market drivers, challenges, trends and regulatory measures taken by the government

* Overview of the government bodies and their responsibilities

* Analysis of the competitive landscape and detailed profiles of major players

Why Buy

* Get a clear understanding of the medical devices market in India, how it operates and the various stages of the value chain

* Understand the current market segmentation and future growth potential of the medical devices market in India till 2018 and plan strategies to gain from it

* Strategize marketing, market-entry, market expansion, and other business plans by understanding factors influencing growth in the market

* Understand your competitor’s business structures, strategies and prospects, and respond accordingly

* Make more informed business decisions with the help of insightful recommendations provided to succeed in the Indian medical devices market.

To order this report:

Email: support@researchonindia.com

US: +1 800 986 6819

UK: +44 203 514 2363

India: +91 22 4098 7600

SOURCE: Researchonindia.com

RELATED LINK:

RELATED VIDEO:

Research on Wind Turbine Market in India

Netscribes latest market research report titled Wind Turbine Market in India 2014 mentions that renewable energy is gaining prominence within the country. Wind energy accounts for majority of the renewable energy generated in the country. With the country facing continuous shortfall in the supply of energy to meet the expanding demands through conventional sources, the focus is shifting from conventional sources of energy to renewable energy. As more and more wind projects are planned for this reason, the market for wind turbines is also expected to grow. Various other reasons such as the high prices and lack of easy availability of raw materials for generating electricity through thermal plants is also driving growth in the market. However, the government’s decision to withdraw various schemes which provided several incentives to wind energy producers is having a negative impact on the markets growth. Off-shore wind energy generation, hybrid generators such as solar photovoltaic and wind and wind and diesel, as well as advent of small wind turbines are some of the trends that can be seen in the industry at present.

Several government and industry bodies are working towards the development of the market and various policy and regulatory incentives are being provided to wind energy producers. However, the market is import dependent. Majority of the players operating in the market are foreign companies and there is stiff competition among these players. The advancements in technology and the resultant reduction in costs will ensure that the market will grow steadily in the next few years.

Coverage

* Overview of the wind turbine market in India and historical and forecasted market size data over 2007 to 2018

* Segmentation of the wind turbine market and cost components of various types of generators

* Export-import overview of wind turbines, value of export-import over 2009-10 to 2012-13 and country-wise value of export-import for 2011-12 and 2012-13

* Qualitative analysis of market drivers, challenges, trends and regulatory measures taken by the government

* Overview of the various industry bodies and their responsibilities

* Analysis of the competitive landscape and detailed profiles of major players

Why Buy

* Get a clear understanding of the wind turbine industry in India, how it operates and the various stages of the value chain

* Understand the current market situation and future growth potential of the wind turbine market in India till 2018 and plan strategies to gain from it

* Strategize marketing, market-entry, market expansion, and other business plans by understanding factors influencing growth in the market and purchase decisions of buyers

* Understand your competitor’s business structures, strategies and prospects, and respond accordingly

* Make more informed business decisions with the help of insightful recommendations provided to succeed in the wind turbine market

To order this report:

Email: support@researchonindia.com

US: +1 800 986 6819

UK: +44 203 514 2363

India: +91 22 4098 7600

SOURCE: Researchonindia.com

RELATED VIDEO:

Tuesday 25 March 2014

Uveitis - Opportunity Analysis and Forecasts to 2017

Summary

Uveitis is an expanding market currently dominated by corticosteroid treatment options as well as off-label immunosuppressive and biologic drugs. Since the conventional corticosteroid treatment is only effective in 50-60% of patients a significant number of patients can be targeted with the new treatment options. While anterior uveitis patients represent the majority of patients, all but one of the new treatments in late stage clinical development target the intermediate, posterior and pan uveitis patient segment. The uveitis market is expected to grow between 2012 and 2017, due to the introduction of biologic drugs as well as a diversification of administrative routes. Market growth is created by the increase in treatment costs and will continue beyond the forecasted time period. The new treatments will target some key unmet needs but opportunities will remain for drugs capable of permanently inhibiting ocular inflammation as well as offering an improved safety profile.

Highlights

Key Questions Answered

* The uveitis market is marked by the presence of a number of unmet needs in current treatments. What are the main unmet needs in this market? Will the drugs under development fulfil the unmet needs of the uveitis market?

* The late-stage uveitis pipeline is filled with diverse molecules and routes of administration. Which drug will have a significant impact on the uveitis market? Which of these drugs will have the highest CAGR, and why?

* The current uveitis market is dominated by corticosteroids as well as off-label immunosuppressive and biologic drugs. How will the introduction of biologic drugs change the treatment landscape once reimbursement is not a problem anymore? How will the drug treatment rates change over the next five years? What are the key drivers and barriers to this change?

Key Findings

* The main driver of the expansion of the uveitis market will be the introduction of biologic drugs, which will increase the market size significantly. The introduction of new ocular administration routes will strengthen the market growth further.

* An additional driver for the uveitis market is the assignment of orphan drug status to several uveitis drugs.

* The biggest barrier for the introduction of the more costly treatment options like biologics will be reimbursement especially in the European markets. To ensure reimbursement companies will have to work closely together with payers and price their drugs competitively.

* Pipeline drugs developed by small to mid-size pharma companies represent a good opportunity for companies to enter the uveitis market and to strengthen their ophthalmology department.

Scope

* Overview of uveitis, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.

* Annualized uveitis therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2012 and forecast for five years to 2017.

* Key topics covered include market characterization, unmet needs, R&D and clinical trials assessment, late stage clinical trial analysis and implications for the uveitis therapeutics market.

* Pipeline analysis: focus on the five late-stage pipeline drugs discussing emerging trends as well as overview of earlier phase drugs.

* Analysis of the current and future market competition in the global uveitis therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

* Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Additionally a list of acquisition targets included in the pipeline product company list.

* Develop business strategies by understanding the trends shaping and driving the global uveitis therapeutics market.

* Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global uveitis therapeutics market in future.

* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

* Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

* Track drug sales in the global uveitis therapeutics market from 2012-2017.

* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

To order this report:

US: +1 800 986 6819

UK: +44 203 514 2363

India: +91 22 4098 7600

RELATED VIDEO:

Kuwait Gas Markets 2013

Summary

This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Kuwait. It details the market structure, regulatory environment, and infrastructure and provides historical and forecasted statistics relating to the supply/demand balance for each of the key sub-segments. It also provides information relating to the natural gas assets (gas fields, pipelines and LNG terminals) in Kuwait. The report compares the investment environment in Kuwait with other countries in the region. The profiles of the major companies operating in the natural gas sector in Kuwait together with the latest news and deals are also included in the report.

Scope

* Historic and forecast data relating to production, consumption, imports, exports and reserves are provided for each industry sub-segment for the period 2000-2020.

* Historical and forecast data and information for all the major gas fields, Liquefied Natural Gas (LNG) Terminals and pipelines in Kuwait for the period 2005-2017.

* Operator and equity details for major natural gas assets in Kuwait.

* Key information relating to market regulations, key energy assets and the key companies operating in the Kuwait’s energy industry.

* Information on the top companies in the Kuwait including business description, strategic analysis, and financial information.

* Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.

* Key mergers and acquisitions, partnerships, private equity and venture capital investments, and IPOs.

Reasons to buy

* Gain a strong understanding of the country’s energy market.

* Facilitate market analysis and forecasting of future industry trends.

* Facilitate decision making on the basis of strong historic and forecast production, reserves and capacity data.

* Assess your competitor’s major natural gas assets and their performance.

* Analyze the latest news and financial deals in the gas sector of each country.

* Develop strategies based on the latest operational, financial, and regulatory events.

* Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market.

* Identify and analyze the strengths and weaknesses of the leading companies in the country.

To order this report:

US: +1 800 986 6819

UK: +44 203 514 2363

India: +91 22 4098 7600

RELATED LINK:

Kuwait Gas Markets 2013

RELATED VIDEO:

Sunday 23 March 2014

Fatty Liver Disease Global Clinical Trials Review, H2, 2013

Summary

Global Data’s clinical trial report, Fatty Liver Disease Global Clinical Trials Review, H2, 2013" provides data on the Fatty Liver Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fatty Liver Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The data book offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Fatty Liver Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Data’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

* Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

* Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

* Understand the dynamics of a particular indication in a condensed manner

* Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

* Obtain discontinued trial listing for trials across the globe

* Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To order this report:

US: +1 800 986 6819

UK: +44 203 514 2363

India: +91 22 4098 7600